Commercial Services and Supplies
Company Overview of Juvenile Diabetes Research Foundation International Inc.
Juvenile Diabetes Research Foundation International Inc. (JDRF) is a not-for-profit organization that focuses on juvenile diabetes cure research and development services. The organization offers grants for diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research companies. JDRF was founded in 1970 and is headquartered in New York City with an additional office in Houston, Texas.
120 Wall Street
New York, NY 10005-4001
Founded in 1970
Key Executives for Juvenile Diabetes Research Foundation International Inc.
Executive Vice President for Development and Chief Operating Officer
Vice President-Customer Services
President of Long Island Chapter
Compensation as of Fiscal Year 2014.
Juvenile Diabetes Research Foundation International Inc. Key Developments
Selecta, JDRF and Sanofi Extend Collaboration to Develop Synthetic Vaccine Particle Immunotherapy for Type 1 Diabetes
Oct 15 14
Selecta Biosciences, Inc., and JDRF, announced that they have extended their joint research collaboration and attracted Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle (SVP) immunotherapy with the long-term goal to treat and potentially prevent the underlying cause of type 1 diabetes. This collaborative research program is aimed at accelerating the advancement of an SVP immunotherapy designed to reset the immune system and restore tolerance to substances (antigens) that cause the immune attacks on insulin-producing cells in the pancreas. As part of their collaboration, JDRF and Sanofi are co-financing the program with the aim of advancing the SVP product candidate to the clinic. This next phase of the SVP development program has been structured as a grant award to Selecta in order to test up to four antigens that may succeed in stopping the autoimmune response that destroys beta cells.
Juvenile Diabetes Research Foundation International Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014
Sep 10 14
Juvenile Diabetes Research Foundation International Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.
Juvenile Diabetes Research Foundation International Names Stephen L. Newman as Vice Chairman of the International Board of Directors for the Organization
Sep 10 14
Juvenile Diabetes Research Foundation International announced that Stephen L. Newman has been named as Vice Chairman of the International Board of Directors for the organization, and will become a member of the Executive Committee. Dr. Newman has been a member of JDRF's IBOD for two years serving on the Advocacy and Finance Committees. He is retired Chief Operating Officer and Vice Chairman of Tenet Healthcare Corporation (THC) and is currently a Strategic Advisor at Gryphon Investors. Dr. Newman served as president and CEO of Columbia/HCA's Louisville Healthcare Network, and is a member of the board of directors of Hansen Medical Inc., and also currently serves on the Federal Reserve Bank of Atlanta's Labor, Education and Healthcare Council and recently completed a five-year term on the board of directors of the Federation of American Hospitals.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries